https://www.medscape.com/viewarticle/998375
0
0
11/11/23 at 8:14pm
Organization
Medscape
Author
Ted Bosworth
31 words
0
Comments
The randomized ORBITA-2 trial, unlike the preceding ORBITA trial, shows benefit for percutaneous coronary intervention in patients with stable angina.
You are the first to view
Create an account
or login to join the discussion